Come up with a name for your new list and we'll add to it:
Nordic NanoVector raised a round of funding on September 27, 2013. Investors include
HealthCap Venture Capital.
Nordic Nanovector is focusing on the development and commercialization of novel targeted therapeutics for haematological cancers. The Company's lead clinical-stage product opportunity is Betalutin, th…